EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 96 filers reported holding EPIZYME INC in Q2 2022. The put-call ratio across all filers is 5.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $46,807,000 | -2.0% | 31,841,394 | +0.0% | 18.49% | -4.8% |
| Q1 2022 | $47,750,000 | +108.4% | 31,833,334 | +247.3% | 19.42% | +102.5% |
| Q4 2021 | $22,917,000 | -51.2% | 9,166,667 | 0.0% | 9.59% | -56.2% |
| Q3 2021 | $46,933,000 | -38.4% | 9,166,667 | 0.0% | 21.90% | -41.0% |
| Q2 2021 | $76,175,000 | -4.6% | 9,166,667 | 0.0% | 37.14% | +23.9% |
| Q1 2021 | $79,842,000 | -19.8% | 9,166,667 | 0.0% | 29.97% | -1.9% |
| Q4 2020 | $99,550,000 | -9.0% | 9,166,667 | 0.0% | 30.54% | +86.3% |
| Q3 2020 | $109,358,000 | -25.7% | 9,166,667 | 0.0% | 16.39% | -42.4% |
| Q2 2020 | $147,217,000 | +3.5% | 9,166,667 | 0.0% | 28.46% | -35.5% |
| Q1 2020 | $142,175,000 | -13.3% | 9,166,667 | +37.5% | 44.14% | +19.0% |
| Q4 2019 | $164,000,000 | – | 6,666,667 | – | 37.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |